Health
Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered – News-Medical.Net
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding…
The main thrust of scientific research on therapeutics to counter the ongoing coronavirus disease 2019 (COVID-19) pandemic has been aimed at identifying drugs and antibodies that can act against the entry of the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), into the host cell.
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding domain (RBD).
The…
-
Business12 hours agoWarning! These ASX 200 shares were just downgraded
-
Business10 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General8 hours agoFatal house fire at Lake Illawarra under police investigation
-
Business11 hours agoAfter falling more than 20% on its FY25 result, are Inghams shares a buy the dip opportunity?